Were global leaders in NAD+ research With 70,000+ NAD+ users supported and multiple peer-reviewed clinical trials, our in-house Stanford PhD-led Research Team is setting the benchmark for research-driven, clinician-guided NAD+ protocols
Back Klausen, MK, Jensen, ME, Mller, M, et al (6 Sept 2022) 'Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial', JCI Insight, 7/19, e159863
The stimulant-free formulation also matters if you're sensitive to caffeine or other energy-boosting compounds
Feedback from Real Ishin Users Here are some of the real glow stories shared by Ishin customers: It was first time to try this product but it seems effective on detoxification and boost your energy
Of significance to dieting and weight loss is the fact that when people lose excess weight the level of NPY increases which likely is a contributing factor to the inability of most people to keep the weight off
the classic Littlejohns 2014 Neurology cohort (122% higher dementia risk when severely deficient)